Protein kinase CK2 inhibitors: a patent review
Author:
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/13543776.2012.717615
Reference55 articles.
1. THE ENZYMATIC PHOSPHORYLATION OF PROTEINS
2. One‐thousand‐and‐one substrates of protein kinase CK2?
3. Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis
4. How druggable is protein kinase CK2?
5. The Dark Side of Protein Kinase CK2 Inhibition
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cancer selective cell death induction by a bivalent CK2 inhibitor targeting the ATP site and the allosteric αD pocket;iScience;2024-02
2. Discovery and Exploration of Protein Kinase CK2 Binding Sites Using CK2α′Cys336Ser as an Exquisite Crystallographic Tool;Kinases and Phosphatases;2023-11-25
3. Protein Kinase CK2 and Epstein–Barr Virus;Biomedicines;2023-01-26
4. AB668, a novel highly selective protein kinase CK2 inhibitor with a distinct anti-tumor mechanism as compared to CX-4945 and SGC-CK2-1;2022-12-16
5. CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders;Frontiers in Molecular Biosciences;2022-10-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3